Neurocognitive function among HIV-infected children on protease inhibitor -based versus non-protease inhibitor based antiretroviral therapy in Uganda: a pilot study

被引:1
|
作者
Nalwanga, Damalie [1 ,2 ]
Musiime, Victor [1 ,3 ]
Bangirana, Paul [4 ]
Nishiguchi, Erika Phelps [5 ]
Kiggwe, Andrew [2 ]
Ssesanga, Titus [3 ]
Ssenkusu, John M. [6 ]
Musoke, Philippa [1 ]
Cusick, Sarah E. [7 ]
机构
[1] Makerere Univ, Sch Med, Dept Paediat & Child Hlth, Coll Hlth Sci, POB 7072, Kampala, Uganda
[2] Makerere Univ Lung Inst, POB 7749, Kampala, Uganda
[3] Joint Clin Res Ctr, Res Dept, POB 10005, Kampala, Uganda
[4] Makerere Univ, Sch Med, Dept Psychiat, Coll Hlth Sci, POB 7072, Kampala, Uganda
[5] Univ Washington, Dept Paediat, Div Dev Behav Paediat, Seattle, WA 98195 USA
[6] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Coll Hlth Sci, POB 7072, Kampala, Uganda
[7] Univ Minnesota, Dept Paediat, Minneapolis, MN USA
基金
美国国家卫生研究院;
关键词
Neurocognitive function; Children; HIV; ART; NEUROPSYCHOLOGICAL PERFORMANCE; COGNITIVE IMPAIRMENT; NAIVE; DEFICITS; OUTCOMES; CARE; ART;
D O I
10.1186/s12887-021-02676-2
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background HIV infection is associated with significant neurocognitive deficits making maximization of cognitive function among children receiving antiretroviral therapy (ART) a public health imperative. Non-protease inhibitors (non-PIs) achieve higher drug levels in the cerebral spinal fluid (CSF) compared to PIs, potentially leading to better neurocognitive function by reducing CSF viral load and inflammation. ART that maximises children's neurodevelopment and school achievement could result in improved quality of life and productivity as adults, but little research to date has examined whether non-PI ART is associated with better neurocognitive outcomes. We compared the neurocognitive function between children living with HIV receiving PI-based and non PI-based ART. Methods We recruited a consecutive sample of clinically stable Ugandan children living with HIV aged 5-12 years who received PI-based or non PI-based ART for >= 1 year (viral load < 1000 copies). Neurocognitive function was assessed using the Kaufman Assessment Battery for Children, the Test of Variables of Attention, and Bruininks-Oseretsky Test of Motor Proficiency. Age-adjusted neurocognitive z-scores for the two groups were compared using linear regression models in STATA version 13. The Hommel's method was used to adjust for multiple testing. Results We enrolled 76 children living with HIV; 34 on PI ART and 42 on non-PI ART. Mean (+/- SD) age was greater in the non-PI vs. PI group (9.5 +/- 1.9 vs. 8.5 +/- 2.0) years (p = 0.03). Children in the non-PI group had lower socioeconomic scores (5.7 +/- 3.3 vs. 7.4 +/- 2.8, p = 0.02). There was no difference in neurocognitive function between the groups (adjusted p > 0.05) for KABC and TOVA. Children in the PI group had better total BOT scores than their counterparts (46.07 +/- 1.40) vs. 40.51 (1.24), p = 0.03). Conclusions We detected no difference in neurocognitive function among children on PI and non PI-based ART therapy based on KABC and TOVA tests. Children on PI based ART had better motor function than their counterparts. We recommend a prospective study with a larger sample size.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Association of hypercholesterolemia incidence with antiretroviral treatment, including protease inhibitors, among perinatally HIV-infected children
    Tassiopoulos, Katherine
    Williams, Paige L.
    Seage, George R., III
    Crain, Marilyn
    Oleske, James
    Farley, John
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 47 (05) : 607 - 614
  • [32] Protease inhibitor-based antiretroviral therapy in treatment-naive HIV-1-infected patients: the evidence behind the options
    Naggie, Susanna
    Hicks, Charles
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) : 1094 - 1099
  • [33] Recovery From Lipodystrophy in HIV-infected Children After Substitution of Stavudine With Zidovudine in a Non-nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy
    Aurpibul, Linda
    Puthanakit, Thanyawee
    Taejaroenkul, Sineenart
    Sirisanthana, Thira
    Sirisanthana, Virat
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (04) : 384 - 388
  • [34] Lipodystrophy among HIV-infected children and adolescents on highly active antiretroviral therapy in Uganda: a cross sectional study
    Piloya, Thereza
    Bakeera-Kitaka, Sabrina
    Kekitiinwa, Adeodata
    Kamya, Moses R.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15
  • [35] Incidence and risk factors for developing cytomegalovirus retinitis in HIV-infected patients receiving protease inhibitor therapy
    Casado, JL
    Arrizabalaga, J
    Montes, M
    Martí-Belda, P
    Tural, C
    Pinilla, J
    Gutierrez, C
    Portu, J
    Schuurman, R
    Aguirrebengoa, K
    AIDS, 1999, 13 (12) : 1497 - 1502
  • [36] Postprandial response to a physiologic caloric load in HIV-positive patients receiving protease inhibitor-based or nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy
    Thomas-Geevarghese, A
    Raghavan, S
    Minolfo, R
    Holleran, S
    Ramakrishnan, R
    Ormsby, B
    Karmally, W
    Ginsberg, HN
    El-Sadr, WM
    Albu, J
    Berglund, L
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (01) : 146 - 154
  • [37] Low Prolactin and High 20-α-Hydroxysteroid Dehydrogenase Levels Contribute to Lower Progesterone Levels in HIV-Infected Pregnant Women Exposed to Protease Inhibitor-Based Combination Antiretroviral Therapy
    Papp, Eszter
    Balogun, Kayode
    Banko, Nicole
    Mohammadi, Hakimeh
    Loutfy, Mona
    Yudin, Mark H.
    Shah, Rajiv
    MacGillivray, Jay
    Murphy, Kellie E.
    Walmsley, Sharon L.
    Silverman, Michael
    Serghides, Lena
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (10) : 1532 - 1540
  • [38] EFFICACY OF NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR-BASED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN THAI HIV-INFECTED CHILDREN AGED TWO YEARS OR LESS
    Puthanakit, Thanyawee
    Aurpibul, Linda
    Sirisanthana, Thira
    Sirisanthana, Virat
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (03) : 246 - 248
  • [39] Clinical outcomes of HIV-infected patients with Kaposi's sarcoma receiving nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy in Uganda
    Asiimwe, F. M.
    Moore, D. M.
    Were, W.
    Nakityo, R.
    Campbell, J.
    Barasa, A.
    Mermin, J.
    Kaharuza, F.
    HIV MEDICINE, 2012, 13 (03) : 166 - 171
  • [40] Cancer Risk and Use of Protease Inhibitor or Nonnucleoside Reverse Transcriptase Inhibitor-Based Combination Antiretroviral Therapy: The D:A:D Study
    Bruyand, Mathias
    Ryom, Lene
    Shepherd, Leah
    Fatkenheuer, Gerd
    Grulich, Andrew
    Reiss, Peter
    de Wit, Stephane
    Monforte, Antonella d'Arminio
    Furrer, Hansjakob
    Pradier, Christian
    Lundgren, Jens
    Sabin, Caroline
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 68 (05) : 568 - 577